Which substances are included in the treatment for stimulant-related disorders?

The inclusion of all the substances mentioned—cocaine, amphetamines, and cathinones—in the treatment for stimulant-related disorders reflects the need to address the various types of stimulants that can lead to substance use disorders.

Cocaine and amphetamines are classic stimulants that can lead to significant psychological and physiological symptoms upon use, including addiction. Treatment for stimulant-related disorders may involve a combination of psychoeducation, behavioral therapies, and, in some cases, pharmacotherapy to manage withdrawal symptoms or co-occurring mental health issues.

Cathinones, commonly referred to as "bath salts," are a newer category of synthetic stimulants that can produce effects similar to both cocaine and amphetamines but may carry different risks and treatment considerations. Including all these substances under one umbrella in treatment protocols ensures that practitioners are prepared to address a variety of clinical presentations and develop comprehensive treatment plans.

By recognizing that treatment approaches need to be flexible and inclusive of different stimulant substances, healthcare providers can tailor interventions to better meet the needs of individuals affected by stimulant-related disorders, thereby enhancing the effectiveness of care.